{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:54:46Z","timestamp":1774994086045,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3901,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1111\/j.1538-7836.2012.04654.x","type":"journal-article","created":{"date-parts":[[2012,2,9]],"date-time":"2012-02-09T16:18:34Z","timestamp":1328804314000},"page":"622-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":420,"title":["Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)"],"prefix":"10.1016","volume":"10","author":[{"given":"P.","family":"KNOEBL","sequence":"first","affiliation":[]},{"given":"P.","family":"MARCO","sequence":"additional","affiliation":[]},{"given":"F.","family":"BAUDO","sequence":"additional","affiliation":[]},{"given":"P.","family":"COLLINS","sequence":"additional","affiliation":[]},{"given":"A.","family":"HUTH\u2010K\u00dcHNE","sequence":"additional","affiliation":[]},{"given":"L.","family":"NEMES","sequence":"additional","affiliation":[]},{"given":"F.","family":"PELLEGRINI","sequence":"additional","affiliation":[]},{"given":"L.","family":"TENGBORN","sequence":"additional","affiliation":[]},{"given":"H.","family":"L\u00c9VESQUE","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0950-3536(96)80067-9","article-title":"Acquired inhibitors","volume":"9","author":"Cohen","year":"1996","journal-title":"Baillieres Clin Haematol"},{"issue":"Suppl 1","key":"10.1111\/j.1538-7836.2012.04654.x_bb0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1538-7836.2011.04309.x","article-title":"Management of acquired haemophilia A","volume":"9","author":"Collins","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2141.2003.04162.x","article-title":"Acquired haemophilia: review and meta\u2010analysis focused on therapy and prognostic factors","volume":"121","author":"Delgado","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0950-3536(98)80049-8","article-title":"Acquired haemophilia","volume":"11","author":"Hay","year":"1998","journal-title":"Baillieres Clin Haematol"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0030","series-title":"Textbook of Hemophilia","first-page":"86","article-title":"Acquired inhibitors to factor VIII","author":"Kessler","year":"2007"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11739-010-0380-y","article-title":"Diagnosis, laboratory aspects and management of acquired hemophilia A","volume":"5","author":"Toschi","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1756-0500-3-161","article-title":"Consensus recommendations for the diagnosis and treatment of acquired hemophilia A","volume":"3","author":"Collins","year":"2010","journal-title":"BMC Res Notes"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0045","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1182\/blood.V60.5.1103.1103","article-title":"Inactivation of factor VIII coagulant activity by two different types of human antibodies","volume":"60","author":"Gawryl","year":"1982","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","article-title":"A survey of 215 non\u2010hemophilic patients with inhibitors to Factor VIII","volume":"45","author":"Green","year":"1981","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0055","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2\u2010year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0060","unstructured":"World Medical Association. Declaration of Helsinki; 59th WMA General Assembly, Seoul, Korea, October 2008. http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/. Accessed 1 August 2011."},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0065","first-page":"612","article-title":"Proceedings: a more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0038-1653759","article-title":"The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability","volume":"73","author":"Verbruggen","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0075","unstructured":"European Commission. Demographic change in the EU. http:\/\/ec.europa.eu\/social\/main.jsp?catId=502&langId=en. Accessed 1 August 2011."},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0080","first-page":"93","article-title":"Acquired factor VIII and factor IX inhibitors: survey of the Italian haemophila centers (AICE)","volume":"88","author":"Baudo","year":"2003","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0085","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood.V81.6.1513.1513","article-title":"Use of porcine factor VIII in the treatment of patients with acquired hemophilia","volume":"81","author":"Morrison","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0090","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2008.001743","article-title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","volume":"94","author":"Huth\u2010Kuhne","year":"2009","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood-2008-03-143586","article-title":"Acquired factor VIII inhibitors","volume":"112","author":"Franchini","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2008.05.003","article-title":"Laboratory, clinical and therapeutic aspects of acquired hemophilia A","volume":"395","author":"Franchini","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2516.2007.01474.x","article-title":"Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal","volume":"13","author":"Sumner","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2516.2005.01060.x","article-title":"Rituximab for autoimmune haemophilia: a proposed treatment algorithm","volume":"11","author":"Aggarwal","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MBC.0b013e32832ca388","article-title":"The prognosis and treatment of acquired hemophilia: a systematic review and meta\u2010analysis","volume":"20","author":"Bitting","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ajh.10070","article-title":"Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone","volume":"69","author":"Lian","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00277-008-0665-7","article-title":"Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland","volume":"88","author":"Tiede","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-0029-1214150","article-title":"Extracorporeal immunoadsorption for the treatment of coagulation inhibitors","volume":"35","author":"Franchini","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0135","first-page":"86","article-title":"Management of severe hemorrhage and inhibitor elimination in acquired hemophilia: the modified Heidelberg\u2010Malm\u00f6 protocol","volume":"88","author":"Huth\u2010K\u00fchne","year":"2003","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0140","first-page":"64","article-title":"New protocol for immune tolerance induction in acquired hemophilia","volume":"85","author":"Nemes","year":"2000","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0145","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1182\/blood-2004-05-1811","article-title":"Treatment of acquired hemophilia by the Bonn\u2010Malmo Protocol: documentation of an in vivo immunomodulating concept","volume":"105","author":"Zeitler","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1567-5688(09)71825-2","article-title":"Immunoadsorption in the treatment of acquired haemophilia","volume":"10","author":"Zeitler","year":"2009","journal-title":"Atheroscler Suppl"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0155","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1365-2141.1996.d01-1965.x","article-title":"Low response to high\u2010dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor","volume":"95","author":"Crenier","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood.V86.2.797.bloodjournal862797","article-title":"A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high\u2010dose intravenous gammaglobulin","volume":"86","author":"Schwartz","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0165","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(84)90701-3","article-title":"Anti\u2010idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high\u2010dose intravenous gammaglobulin","volume":"2","author":"Sultan","year":"1984","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1111\/j.1538-7836.2012.04654.x_bb0170","article-title":"Epidemiology and one\u2010year outcomes in patients with acquired hemophilia in France","volume":"5","author":"Borg","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04654.x_bb0175","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/0003-4819-110-10-774","article-title":"Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor","volume":"110","author":"Lian","year":"1989","journal-title":"Ann Intern Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2012.04654.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622062377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622062377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2012.04654.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:59:44Z","timestamp":1761533984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622062377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1538783622062377"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04654.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04654.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}